Shivanand Kumatagi Delivered Session on ISBT 128 at KMC Manipal
Shivanand Kumatagi, Development Officer (India) at ICCBBA, shared on LinkedIn:
”Insightful session on ISBT 128 at KMC Manipal
Had the privilege of delivering a lecture to the Postgraduate students of Transfusion Medicine KMC Manipal.
The session focused on Traceability in Transfusion Medicine—its challenges and the critical role of standardized labeling.
We discussed recent reports of suspected transfusion-transmitted HIV cases in Jharkhand, highlighting the urgent need for robust traceability mechanisms.
I emphasized how ISBT 128 standard labeling can significantly enhance Traceability and help mitigate transfusion-transmitted infections across India.
I also showcased ISBT 128 -compliant labels from Indian centers that have already adopted the standard—demonstrating real-world implementation and its impact on improving safety and accountability.
A special thanks to Eoin McGrath for joining us online and contributing to an extended and enriching discussion.
Grateful to the Transfusion Medicine KMC Manipal for hosting me.
It was a truly interactive experience, and I deeply appreciated the insights shared by the esteemed faculty of one of India’s leading institutes in Transfusion Medicine.
Looking forward to more such meaningful engagements that strengthen safe transfusion practices in India.”
Stay updated with Hemostasis Today.
-
Jul 5, 2026, 04:54Saneha Anjum Shaik: What Every Clinician Should Know Before Ordering Blood Tests
-
Jul 5, 2026, 04:37Mathis Richter: How The Bone Marrow Responds To Myocardial Infarction Predicts Clinical Outcome
-
Jul 5, 2026, 02:45Marie Luise Hütter-Krönke: Can a Short Course of BCMA-Targeted Therapy Induce Long-Term Remission in Refractory Autoimmune Disease?
-
Jul 5, 2026, 02:24Shreya Agarwa: Transforming Care For Adolescents With Heavy Menstrual Bleeding
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins